2021
DOI: 10.31363/2313-7053-2021-56-3-45-61
|View full text |Cite
|
Sign up to set email alerts
|

The incidence of depressive disorders in patients with schizophrenia

Abstract: Summary. Introduction. Historically, depressive disorders have been described in various forms of schizophrenia by Kraepelin (1923) or as a reaction to illness by Bleuler (1922). One of the alternative points of view that has been considered in recent years is that depressive disorders are a comorbid condition of schizophrenia or one of the manifestations of schizophrenia. However, to date, depression, as a symptom, is not included in the diagnostic criteria of the ICD-10. Methodological approaches to diagnosi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(3 citation statements)
references
References 52 publications
0
3
0
Order By: Relevance
“…An interesting question is the influence of gender, ethnicity, and race of patients on the realization of genetic predisposition in the pathological phenotype of comorbidity of schizophrenia and depression. On the one hand, our earlier meta-analysis of the incidence of comorbidity of schizophrenia and depression in the world did not demonstrate statistically significant gender differences, although we showed a higher incidence of this phenotype in patients with schizophrenia in the Middle East, Southeast Asia, and Russia [ 13 ] On the other hand, it is difficult to assess the influence of patients’ age on the realization of a genetic predisposition to the development of this endophenotype (schizophrenia + depression), since not all the publications we analyzed provided sufficient data for subsequent statistical processing.…”
Section: Limitationsmentioning
confidence: 69%
See 2 more Smart Citations
“…An interesting question is the influence of gender, ethnicity, and race of patients on the realization of genetic predisposition in the pathological phenotype of comorbidity of schizophrenia and depression. On the one hand, our earlier meta-analysis of the incidence of comorbidity of schizophrenia and depression in the world did not demonstrate statistically significant gender differences, although we showed a higher incidence of this phenotype in patients with schizophrenia in the Middle East, Southeast Asia, and Russia [ 13 ] On the other hand, it is difficult to assess the influence of patients’ age on the realization of a genetic predisposition to the development of this endophenotype (schizophrenia + depression), since not all the publications we analyzed provided sufficient data for subsequent statistical processing.…”
Section: Limitationsmentioning
confidence: 69%
“…Methodological differences in diagnosis and time course of evaluation mean that there is a wide variance of depressive symptoms reported by patients with schizophrenia in the literature, with prevalence rates as high as 61% [ 12 ]. Nevertheless, reviews of the literature convincingly show that depression is elevated in schizophrenia [ 13 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation